Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $153.61 Analyst target: $167.17 Upside: 8.83%
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.